Dodd P R, Watson W E, Johnston G A
Clin Exp Pharmacol Physiol. 1986 Oct;13(10):711-22. doi: 10.1111/j.1440-1681.1986.tb02412.x.
Representative A1 site- and A2 site-selective ligands for adenosine receptors were found to bind to a single class of non-co-operative sites in synaptic membranes prepared from pieces of normal human temporal lobe cerebral cortex obtained at autopsies performed within 24 h post-mortem. The known adenosine antagonists theophylline and 1-isobutyl-3-methylxanthine also bound to these sites and could completely displace either ligand. Computer analysis combining data from 21 separate experiments which used membranes prepared from seven different autopsy cases gave the following kinetic parameters for the site: equilibrium dissociation constants (KD) for L-PIA, 4.1 +/- 0.9 nmol/l; KD for NECA, 26 +/- 4 nmol/l; KD for theophylline, 28 +/- 5 mumol/l; receptor number (Bmax), 510 +/- 77 fmol/mg protein. Carbamazepine could also displace either radioligand from the sites, although solubility limits for this drug were reached at 50% receptor occupancy. The KD for carbamazepine was 138 +/- 18 mumol/l. Other anticonvulsants tested were generally ineffective at their therapeutic concentrations, although phenytoin showed a small amount of ligand binding inhibition. The results are in line with earlier studies in rodent tissue preparations, and suggest a possible purinergic component in the anticonvulsant activity of carbamazepine in a man.
已发现,腺苷受体的典型A1位点和A2位点选择性配体,能与从死后24小时内尸检获取的正常人颞叶皮质切片制备的突触膜中的一类非协同位点结合。已知的腺苷拮抗剂茶碱和1-异丁基-3-甲基黄嘌呤也能与这些位点结合,并能完全取代任何一种配体。综合来自21个独立实验的数据进行计算机分析,这些实验使用了从7个不同尸检病例制备的膜,得出该位点的以下动力学参数:L-PIA的平衡解离常数(KD)为4.1±0.9 nmol/l;NECA的KD为26±4 nmol/l;茶碱的KD为28±5 μmol/l;受体数量(Bmax)为510±77 fmol/mg蛋白质。卡马西平也能从这些位点取代任何一种放射性配体,尽管在受体占有率达到50%时达到了该药物的溶解度极限。卡马西平的KD为138±18 μmol/l。所测试的其他抗惊厥药在其治疗浓度下通常无效,尽管苯妥英显示出少量的配体结合抑制作用。这些结果与早期在啮齿动物组织制备中的研究一致,并表明卡马西平在人体内的抗惊厥活性中可能存在嘌呤能成分。